MODEL-AD's Avatar

MODEL-AD

@model-ad.bsky.social

Model Organism Development and Evaluation for Late-onset AD. NIA collaborative effort between IU, JAX, UPitt, UCI & Sage Bionetworks to develop new models for LOAD for unrestricted use. www.model-ad.org

259 Followers  |  3 Following  |  2 Posts  |  Joined: 06.12.2023  |  1.4377

Latest posts by model-ad.bsky.social on Bluesky

MODEL-AD Probably Has Something for You | ALZFORUM

We probably have something for you! www.alzforum.org/news/confere...

18.11.2024 14:54 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Mouse Model LOADs on the Alzheimer’s Risk Factors | ALZFORUM

AlzForum reports on our latest MODEL-AD efforts to study late-onset Alzheimer's disease in mice starting from genetic and environmental risk factors rather than familial transgenes: #EndALZ @model-ad.bsky.social

19.01.2024 16:46 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
In vivo validation of late-onset Alzheimer's disease genetic risk factors https://www.biorxiv.org/content/10.1101/2023.12.21.572849v1 Introduction: Genome-wide association studies have identified over 70 genetic loci associated with l

In vivo validation of late-onset Alzheimer's disease genetic risk factors https://www.biorxiv.org/content/10.1101/2023.12.21.572849v1

24.12.2023 06:16 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease https://www.biorxiv.org/content/10.1101/2023.12.22.573059v1 INTRODUCTION: Increasing evidence suggests that metabolic impairments contribute to early Alzheimer'

Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease https://www.biorxiv.org/content/10.1101/2023.12.22.573059v1

22.12.2023 22:15 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology https://www.biorxiv.org/content/10.1101/2023.12.19.571985v1 INTRODUCTION: MODEL-AD is creating and distributing novel mouse models with humanized, clinically re

Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology https://www.biorxiv.org/content/10.1101/2023.12.19.571985v1

20.12.2023 12:16 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

MARMO-AD has arrived on BlueSky! Follow us for research updates and news from the MARMO-AD team.

13.12.2023 16:09 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

MODEL-AD has arrived!

Follow us for updates on new mouse models for Alzheimer's research, open data resources from animal models, and where to find us at your favorite conferences. #EndAlz

06.12.2023 16:13 β€” πŸ‘ 8    πŸ” 4    πŸ’¬ 2    πŸ“Œ 0

@model-ad is following 3 prominent accounts